Publicaciones (46) Publicaciones en las que ha participado algún/a investigador/a

2009

  1. Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer

    Lung Cancer, Vol. 64, Núm. 1, pp. 124-126

  2. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of Pemphigus vulgaris

    Experimental Dermatology, Vol. 18, Núm. 9, pp. 771-780

  3. Analysis of POSSUM score and postoperative morbidity in patients with rectal cancer undergoing surgery

    Langenbeck's Archives of Surgery, Vol. 394, Núm. 1, pp. 55-63

  4. Anti-angiogenic therapy in ovarian cancer: A great expectation to be confi rmed

    Clinical and Translational Oncology

  5. Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin

    Journal of Neuro-Oncology, Vol. 94, Núm. 2, pp. 279-281

  6. Clinical development of combination strategies in immunotherapy: Are we ready for more than one investigational product in an early clinical trial?

    Immunotherapy, Vol. 1, Núm. 5, pp. 845-853

  7. Current status of anti-angiogenic agents in the treatment of ovarian carcinoma

    Clinical and Translational Oncology, Vol. 11, Núm. 9, pp. 589-595

  8. Differential expression in inflammatory-related genes after preoperative chemoradiation (CRT) in normal rectal tissue compared with rectal carcinoma

    EJC SUPPLEMENTS

  9. EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration

    European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486

  10. Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer

    World Journal of Gastroenterology, Vol. 15, Núm. 18, pp. 2290-2292

  11. Guidelines for HER2 testing in breast cancer: A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 11, Núm. 6, pp. 363-375

  12. Hipertensión pulmonar: tratamiento

    Cuadernos del Tomás, Núm. 1, pp. 143-156

  13. Hipopituitarismo secundario debido a metástasis en región hipotalámica de carcinoma microcítico de pulmón

    Endocrinologia y Nutricion, Vol. 56, Núm. 4, pp. 201-204

  14. Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

    British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883

  15. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

    Cancer Research, Vol. 69, Núm. 7, pp. 2887-2895

  16. Immunotherapy of distant metastatic disease

    Annals of Oncology, Vol. 20, Núm. SUPPL. 4

  17. Improved survival in patients with refractory glioblastoma that response to Irinotecan and Bevacizumab

    EJC SUPPLEMENTS

  18. In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb

    European Journal of Immunology, Vol. 39, Núm. 9, pp. 2424-2436

  19. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

    British Journal of Cancer, Vol. 100, Núm. 7, pp. 1111-1119

  20. Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience

    Radiotherapy and Oncology, Vol. 91, Núm. 1, pp. 54-59